Trial Profile
Metreleptin efficacy and pharmacodynamics in overweight or obese patients also on a hypocaloric diet
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2011
Price :
$35
*
At a glance
- Drugs Metreleptin (Primary)
- Indications Obesity; Overweight
- Focus Pharmacodynamics; Therapeutic Use
- 16 Aug 2011 New trial record
- 01 Aug 2011 Results published in the European Journal of Endocrinology.